
AUA 2022
Come visit us at Booth #647 and be sure to pick up a copy of the 2022 Guidelines at a Glance Prostate Cancer Edition, available exclusively at our booth!
The Oncotype DX® tests deliver clinically relevant genomic intelligence specific to the individual biology of a patient’s tumor—equipping physicians with the Exact insights they need.
The Oncomap™ tests deliver rapid and comprehensive tumor profiling that aids therapy selection for patients with advanced or metastatic cancer—utilizing a complete biological picture to match their needs.
Come visit us at Booth #647 and be sure to pick up a copy of the 2022 Guidelines at a Glance Prostate Cancer Edition, available exclusively at our booth!
FOR PATIENTS
It's important to know everything you can about genomic tests; that way, you and your doctor can make an informed decision together.
Exact Sciences believes that everyone should have access to the information they need to make informed decisions about their cancer treatment. That’s why we offer the Genomic Access Program (GAP) to help patients navigate the insurance and billing process.
Helping them avoid over/undertreatment in breast, prostate, and colon cancers.